Enzymatic reduction of hydrazones to hydrazines.
A German university has developed a novel process for the synthesis of hydrazines, compounds for the synthesis of several pharmaceuticals and precursors of natural products. The invention is more efficient and less hazardous than current procedures. The university offers a license and a technical cooperation agreement to the pharmaceutical or chemical industry.
Optically active hydrazine compounds are valuable intermediate compounds for the synthesis of several pharmaceuticals and precursors for natural products. A prominent example is D-(+)-1-Phenyl-2-hydrazinopropan (D-(+)-JB-516), which includes a chiral hydrazine and acts as inhibitor of monoaminooxidase in mice brain. A precursor towards synthesis of the natural compound Manzacidin C also contains a chiral hydrazine as structural motif. So far, hydrazines are prepared usually via traditional chemical synthesis methods. But these methods have several disadvantages, like the risk of generating hydrogen cyanide in an acidic environment as well as only low product yields. Alternative reaction modes using triethylsilane need relatively harsh reaction conditions and long reaction times. A German university now developed a novel process focusing on the enantioselective syntheses of chiral hydrazines. A new route is now described here with the usage of an imine reductase for the reduction of the C=N-double bond of hydrazones (I) to the corresponding hydrazines (II). Especially, in the present innovation, it was shown that imine reductases are valuable biocatalysts for the enantioselective reduction of hydrazones and may therefore be used for synthesis of enantiomeric enriched or pure products (up to 99%). In an improved method, S- and R-selective enzymes may be used to fabricate the product of need. The university offers a license agreement to the pharmaceutical and chemical industry. In order to upscale the invention to an industrial level the university offers also a technical cooperation agreement.
Advantages and innovations
The innovation - compared to existing procedures - lies in the completely different synthesis approach using an enzymatically controlled process. With this procedure, the purely chemical method (use of extremely toxic cyanide compounds) can be completely dispensed with. In addition, the enzyme control also makes it possible to produce the target product almost chirally clean (99%) and without having to separate it from its optical counterpart. Further advantages: • Avoidance of toxic and expensive heavy metal catalysts • Smooth reaction conditions of the process running at ambient temperature • reduction of hazardness in the preparation of hydrazines
Intellectual Property Rights (IPR)
Patent(s) applied for but not yet granted
Register your interest
How it works
- Tell us about yourself
- We’ll discuss with you
- We put the right partners in touch
EEN help you find the right partner, rather than you going it alone.
Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.
These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.
Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.
First we need to check you’re human.
Thank you for verifying your email. We have sent you a confirmation email containing a 6 digit verification code to unlock the form below